xalkori
(Crizotinib)
(250 mg)
(60)
(Tablets)
Xalkori (crizotinib) 250 mg 60 tab Original
Article:
Indications
- Xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer who have abnormal expression of the anaplastic lymphoma kinase (ALK) gene.
- 1890 car
-
Commercial name:xalkori
-
Сhemical name:Crizotinib
-
Dosage:250 mg
-
Quantity:60
-
Release form:Tablets
No reviews yet